Sinusitis News and Research

Latest Sinusitis News and Research

Study estimates 30% of outpatient oral antibiotic prescription in the U.S as inappropriate

Study estimates 30% of outpatient oral antibiotic prescription in the U.S as inappropriate

Good bacteria can help inhibit growth of S. pneumoniae

Good bacteria can help inhibit growth of S. pneumoniae

New GASMAS-based technique shows promise for non-invasive sinusitis diagnostics

New GASMAS-based technique shows promise for non-invasive sinusitis diagnostics

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Breakthrough research to be presented at AAO-HNSF 2015 Annual Meeting & OTO EXPO

Breakthrough research to be presented at AAO-HNSF 2015 Annual Meeting & OTO EXPO

Teva presents new Reslizumab data at European Respiratory Society (ERS) International Congress 2015

Teva presents new Reslizumab data at European Respiratory Society (ERS) International Congress 2015

New Medicare payment model reduces use of low-value services

New Medicare payment model reduces use of low-value services

Smith & Nephew to distribute Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium

Smith & Nephew to distribute Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium

Smith & Nephew becomes exclusive distributor of Scopis TGS system in UK, Ireland and Belgium

Smith & Nephew becomes exclusive distributor of Scopis TGS system in UK, Ireland and Belgium

Common antibiotic azithromycin effectively kills many multidrug-resistant bacteria

Common antibiotic azithromycin effectively kills many multidrug-resistant bacteria

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

New telemedicine plan for underinsured, uninsured individuals

New telemedicine plan for underinsured, uninsured individuals

Meta-analysis supports ambrisentan efficacy

Meta-analysis supports ambrisentan efficacy

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

Hospira announces launch of first biosimilar monoclonal antibody in Europe

Hospira announces launch of first biosimilar monoclonal antibody in Europe

Johns Hopkins researchers reveal that e-cigarettes weaken immune system

Johns Hopkins researchers reveal that e-cigarettes weaken immune system

Two new ODYSSEY trials meet primary efficacy endpoints

Two new ODYSSEY trials meet primary efficacy endpoints

Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche announces launch of cobas Liat System for on-demand testing in different settings

New diagnostic system describes symptoms using the image of patient's tongue

New diagnostic system describes symptoms using the image of patient's tongue

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo announces acquisition of rights to Natesto (testosterone nasal gel)